ASBP
Aspire Biopharma
ASBP
ASBP
57 hedge funds and large institutions have $265M invested in Aspire Biopharma in 2022 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 10 increasing their positions, 9 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
50% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 8
Holders
57
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$3.5M | |
| 2 | +$2.58M | |
| 3 | +$1.86M | |
| 4 |
GCL
Glazer Capital LLC
New York
|
+$1.16M |
| 5 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$898K |
Top Sellers
| 1 | -$6.87M | |
| 2 | -$2.33M | |
| 3 | -$1.44M | |
| 4 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$563K |
| 5 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$507K |